Lemon Balm
Also sold as: Melissa officinalis · Lemon balm leaf · Melissa extract
An aromatic herb studied for anxiety symptoms, stress and subjective sleep quality. Small trials suggest possible benefit, with dose-dependent sedation and uneven effects on cognition.
Anxiety Sleep Focus
Community
Not enough ratings yet: 0 of 10
Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.
Research
- Sleep: One small phytosome crossover and combination-product trials suggest subjective improvement; objective sleep confirmation is lacking.
- Focus: Small acute studies show dose-dependent mixed cognitive effects; calming can coincide with reduced alertness.
- Anxiety: Small heterogeneous trials favor symptom reduction; pooled anxiety SMD-0.98 (95% CI-1.63 to-0.33) is uncertain and not proof of treatment for severe anxiety.
REALITY CHECK // Lemon balm is not a reliably drug-strength tranquilizer. Anxiety meta-analysis estimates look large but come from small heterogeneous trials; sleep findings are mainly subjective and partly combination-based. A phytosome delivery rationale does not guarantee better clinical results.
Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.
Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.
Check your bottle
Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.
Enter the amount from your label to see the result.
How it was studied
UPPER LIMIT // No EFSA or NIH tolerable upper intake level is established.1600 mg/day is a research exposure, not a proven safe maximum. Long-term dependence, tolerance and withdrawal data are inadequate.
Summary
Anxiety and subjective sleep signals are promising but limited by small samples, heterogeneous preparations and regional concentration. The best agitation-aromatherapy trial in Alzheimer disease was null and must not be confused with oral-extract cognitive research.
Mechanism
Rosmarinic/hydroxycinnamic acids may affect GABA metabolism; nicotinic/muscarinic receptor binding is demonstrated in vitro. These are mechanistic hypotheses rather than proven causes of human behavioral effects.
Typical studied dose
Extract studies span roughly300–1600 mg/day, commonly300–600 mg; the range pools different preparations and endpoints. A small Alzheimer trial used60 drops/day for4 months, which cannot be converted into mg without the specific liquid concentration.
Upper limit
No EFSA or NIH tolerable upper intake level is established.1600 mg/day is a research exposure, not a proven safe maximum. Long-term dependence, tolerance and withdrawal data are inadequate.
Popular stacks with Lemon Balm
Not enough stack data yet. A combination with Lemon Balm appears here once 5 people rate the same set.
Forms and label traps
| Form on label | Active content | Studied range / day | Absorption & GI tolerance | Verdict |
|---|---|---|---|---|
| Lemon balm standardized extract Best for: Match exact preparation and declared extract mass. |
Extract weight · marker not quantified | 300–1600 mg | Marker content and preparation vary; receptor-binding findings do not prove a clinical absorption advantage. Generally tolerated; occasional stomach discomfort and sedation. |
Studied standard [FORM // TRIAL_CONTEXT] Compare full extract mass; rosmarinic-acid percentage is unknown here and displayed as0 rather than invented100%. The pooled interval is not a dose recommendation. |
| Dried leaf infusion Best for: Compare the exact preparation and declared ingredient mass. |
Unstandardized: active content unknown | no comparable trial range | No reliable human head-to-head superiority established. Digestive tolerance varies; stop for persistent symptoms. |
Caution [FORM // NO_VALIDATED_RANGE] No declared herb-to-extract ratio or validated trial range. Tea leaf mass is not equivalent to standardized extract. |
| Ethanolic liquid extract Best for: Compare the exact preparation and declared ingredient mass. |
Unstandardized: active content unknown | no comparable trial range | Composition depends on solvent and concentration. Contains alcohol; relevant to driving and interacting sedatives. |
Caution [FORM // NO_VALIDATED_RANGE] The Alzheimer study used60 drops/day; drop mass and extract concentration are not supplied, so no mg conversion is performed. |
| Lemon balm phytosome Best for: Compare the exact preparation and declared ingredient mass. |
Unstandardized: active content unknown | no comparable trial range | A small crossover sleep study used this specific preparation; delivery claims are formulation-specific. Digestive tolerance varies; stop for persistent symptoms. |
Caution [FORM // NO_VALIDATED_RANGE] Exact preparation-specific trial mass is unavailable in the dossier; do not import a generic extract target. |
Common label traps
- TRAP_01 // MORE IS ALWAYS MORE CALM
Higher doses sometimes worsened cognitive measures or alertness; effects are nonmonotonic. - TRAP_02 // SLEEP BLENDS PROVE LEMON BALM ALONE
Valerian, melatonin and other coingredients confound attribution and may increase next-day drowsiness. - TRAP_03 // PHYTOSOME IS MANDATORY
A small preparation-specific sleep study does not establish superiority for every indication. - TRAP_04 // PROVEN IBS REMEDY
GI evidence concerns multi-herb STW preparations and cannot isolate lemon balm.
Other outcomes studied
Outside the five leaderboard goals. Same evidence levels as above.
- DEPRESSIVE SYMPTOMS Limited · benefit
Meta-analysis: SMD-0.47 (95% CI-0.73 to-0.21,p=0.0005); small heterogeneous trials limit certainty and do not justify replacing treatment.
PMID 34449930 - ACUTE LABORATORY STRESS Limited · benefit
Small healthy-volunteer studies found calmer mood, sometimes reduced alertness; food and valerian combinations do not isolate every ingredient effect.
PMID 15272110 PMID 25360512 PMID 16444660 - ALZHEIMER COGNITION / ORAL Limited · benefit
Single42-patient4-month trial in adults65–80 used60 drops/day; ADAS-cog F=6.93,p=0.01 and CDR F=16.87,p<0.0001 favored extract. Small single-center evidence remains unreplicated.
PMID 12810768 - ALZHEIMER AGITATION / AROMATHERAPY Limited · no benefit
A stronger placebo-controlled trial did not confirm an agitation advantage; this route/outcome is distinct from oral cognitive extract studies.
PMID 21335973 - BENIGN PALPITATIONS Limited · benefit
One small2-week trial suggested reduced episodes and anxiety in benign functional palpitations; unexplained palpitations require medical evaluation.
PMID 25680840 - FUNCTIONAL GI SYMPTOMS Limited · benefit
STW multi-herb preparation findings cannot establish lemon-balm monotherapy efficacy. One source concerns STW5-II while another concerns STW5; compositions must not be conflated.
PMID 39978315 PMID 16765572
Reader questions
Can I take it daily without dependence?
Short trials do not establish long-term tolerance, dependence or withdrawal risk. There is no validated cycling protocol; review continued need and persistent symptoms with a clinician.
Is a3000 mg label too much?
Check whether the label means leaf-equivalent or actual extract. Research preparations span roughly300–1600 mg/day, but no established UL means3000 mg is not automatically safe or unsafe from that comparison alone.
Can it calm me during the day without sleepiness?
Possibly, but small acute studies sometimes reduced alertness. Test personal tolerance away from driving; dose escalation is not reliably beneficial.
Can I add it to psychiatric or sleep medication?
Sedative combinations need pharmacist/clinician review; receptor mechanisms do not establish safety of a particular stack.
Can it treat my palpitations?
The small trial concerned benign functional episodes. New, persistent or symptomatic palpitations need assessment rather than self-treatment.
Stack interactions
- Caution CNS depressants, alcohol and sedative stacks [CAUTION // CLINICAL_CONTEXT]
Additive drowsiness is plausible; clinical interaction magnitude is unestablished. Discuss hypnotics, benzodiazepines, opioids and other sedative combinations with a pharmacist.
PMID 33561990 - Caution Thyroid disease / levothyroxine [CAUTION // CLINICAL_CONTEXT]
In vitro inhibition of Graves-immunoglobulin/TSH receptor-related activity is a precautionary signal, not evidence of human thyroid suppression or a reason to change medication.
PMID 2985357 - Caution Cholinergic / anticholinergic medicines [CAUTION // CLINICAL_CONTEXT]
In vitro nicotinic/muscarinic receptor binding suggests a theoretical pharmacodynamic concern; a clinical interaction is not demonstrated.
PMID 12888775
Red flags: interactions and who should avoid it
Interactions
Potential additive drowsiness with alcohol, hypnotics, benzodiazepines, opioids and sedating herbs. Thyroid and cholinergic interactions remain theoretical/preclinical, not demonstrated clinical interactions.
Avoid or ask a doctor first if
Pregnancy/breastfeeding and pediatric safety data are limited. Discuss thyroid disease/medication and surgery with the treating team. Avoid driving if drowsy; stop for substantial paradoxical anxiety, low mood or troublesome sedation.
Sources (PubMed, 15)
- The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta-analysis.
PMID 34449930 · 2021 · systematic review / meta-analysisHeterogeneous clinical anxiety/depression synthesis with reported standardized effects.
- Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm).
PMID 15272110 · 2004 · randomized controlled trialSmall acute stress study with calming and reduced alertness.
- Anti-stress effects of lemon balm-containing foods.
PMID 25360512 · 2014 · randomized controlled trialAnti-stress results from lemon-balm-containing foods.
- Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress.
PMID 16444660 · 2006 · randomized controlled trialValerian combination, no isolated lemon-balm effect.
- Effects of Melissa officinalis Phytosome on Sleep Quality: Results of a Prospective, Double-Blind, Placebo-Controlled, and Cross-Over Study.
PMID 39683592 · 2024 · randomized controlled trialSmall phytosome subjective-sleep crossover trial.
- Effect of a nutraceutical combination on sleep quality among people with impaired sleep: a randomised, placebo-controlled trial.
PMID 38580720 · 2024 · randomized controlled trialCombination nutraceutical sleep trial, attribution limited.
- Herbal Remedies and Their Possible Effect on the GABAergic System and Sleep.
PMID 33561990 · 2021 · systematic review / meta-analysisMechanistic GABA/sleep review and sedation rationale.
- Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm).
PMID 12062586 · 2002 · randomized controlled trialAcute mood/cognitive modulation with mixed dose-dependent responses.
- Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties.
PMID 12888775 · 2003 · randomized controlled trialHuman acute study plus in vitro receptor-binding rationale.
- Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial.
PMID 12810768 · 2003 · randomized controlled trialSmall oral-extract Alzheimer trial, not aromatherapy.
- A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease.
PMID 21335973 · 2011 · randomized controlled trialNull agitation-aromatherapy result in Alzheimer disease.
- Heart palpitation relief with Melissa officinalis leaf extract: double blind, randomized, placebo controlled trial of efficacy and safety.
PMID 25680840 · 2015 · randomized controlled trialSmall benign-palpitation trial.
- Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
PMID 2985357 · 1985 · in vitro studyPreclinical receptor-binding thyroid signal only.
- STW 5-II for Treatment of Functional Gastrointestinal Disorders: Mechanism and Clinical Efficacy.
PMID 39978315 · 2025 · narrative reviewMulti-herb STW5-II review, not lemon-balm monotherapy.
- Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum.
PMID 16765572 · 2006 · in vitro studyRegional gastric preparation/component pharmacology.
Community comments
No approved comments yet. Comments are held for moderation.